United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83324-108_3593ed8b-e442-830c-e063-6294a90a7afb
- Product NDC
- 83324-108
- Form
- TABLET, COATED
- Composition / generic term
- NAPROXEN SODIUM
- Labeler
- CHAIN DRUG MARKETING ASSOCIATION, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250520
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (83324-108-01) / 100 TABLET, COATED in 1 BOTTLE, PLASTIC · 83324-108-01
- 1 BOTTLE, PLASTIC in 1 CARTON (83324-108-24) / 24 TABLET, COATED in 1 BOTTLE, PLASTIC · 83324-108-24
- 1 BOTTLE, PLASTIC in 1 CARTON (83324-108-50) / 50 TABLET, COATED in 1 BOTTLE, PLASTIC · 83324-108-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →